Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 5
1949 2
1951 3
1953 1
1955 1
1956 1
1957 1
1961 1
1962 1
1964 2
1966 1
1967 1
1968 2
1969 2
1976 2
1978 7
1979 2
1980 5
1981 2
1982 4
1983 3
1984 1
1985 6
1986 2
1987 2
1988 2
1989 3
1990 4
1991 3
1992 6
1993 7
1994 19
1995 11
1996 9
1997 4
1998 11
1999 7
2000 10
2001 11
2002 15
2003 12
2004 24
2005 31
2006 15
2007 17
2008 28
2009 29
2010 30
2011 20
2012 33
2013 34
2014 34
2015 39
2016 39
2017 41
2018 41
2019 33
2020 41
2021 50
2022 40
2023 43
2024 49
2025 35

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

852 results

Results by year

Filters applied: . Clear all
Page 1
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. Humbert M, et al. Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237. Eur Heart J. 2022. PMID: 36017548 No abstract available.
Treatment algorithm for pulmonary arterial hypertension.
Chin KM, Gaine SP, Gerges C, Jing ZC, Mathai SC, Tamura Y, McLaughlin VV, Sitbon O. Chin KM, et al. Eur Respir J. 2024 Oct 31;64(4):2401325. doi: 10.1183/13993003.01325-2024. Print 2024 Oct. Eur Respir J. 2024. PMID: 39209476 Free PMC article. Review.
Rebuttal From Drs Weatherald and Sitbon.
Weatherald J, Sitbon O. Weatherald J, et al. Chest. 2024 Mar;165(3):496-498. doi: 10.1016/j.chest.2023.10.002. Chest. 2024. PMID: 38461013 No abstract available.
Pulmonary arterial hypertension.
Boucly A, Gerges C, Savale L, Jaïs X, Jevnikar M, Montani D, Sitbon O, Humbert M. Boucly A, et al. Presse Med. 2023 Sep;52(3):104168. doi: 10.1016/j.lpm.2023.104168. Epub 2023 Jul 28. Presse Med. 2023. PMID: 37516248 Review.
Macitentan and morbidity and mortality in pulmonary arterial hypertension.
Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Jing ZC, Le Brun FO, Mehta S, Mittelholzer CM, Perchenet L, Sastry BK, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G; SERAPHIN Investigators. Pulido T, et al. N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917. N Engl J Med. 2013. PMID: 23984728 Free article. Clinical Trial.
Drugs targeting novel pathways in pulmonary arterial hypertension.
Sitbon O, Boucly A, Weatherald J, Antigny F, Guignabert C, Jevnikar M, Jaïs X, Price LC, Wilkins MR, Zamanian RT, Savale L, Montani D, Humbert M. Sitbon O, et al. Eur Respir J. 2025 Aug 8;66(2):2401830. doi: 10.1183/13993003.01830-2024. Print 2025 Aug. Eur Respir J. 2025. PMID: 40341051 Review.
Portopulmonary Hypertension.
Savale L, Watherald J, Sitbon O. Savale L, et al. Semin Respir Crit Care Med. 2017 Oct;38(5):651-661. doi: 10.1055/s-0037-1606251. Epub 2017 Oct 17. Semin Respir Crit Care Med. 2017. PMID: 29041033 Review. No abstract available.
Sarcoidosis-Associated Pulmonary Hypertension.
Savale L, Dorfmüller P, Boucly A, Jaïs X, Lacoste-Palasset T, Jevnikar M, Seferian A, Humbert M, Sitbon O, Montani D. Savale L, et al. Clin Chest Med. 2024 Mar;45(1):185-197. doi: 10.1016/j.ccm.2023.08.007. Epub 2023 Sep 1. Clin Chest Med. 2024. PMID: 38245366 Review.
Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension.
Boucly A, Beurnier A, Turquier S, Jevnikar M, de Groote P, Chaouat A, Cheron C, Jaïs X, Picard F, Prévot G, Roche A, Solinas S, Cottin V, Bauer F, Montani D, Humbert M, Savale L, Sitbon O; PulmoTension Network. Boucly A, et al. Eur Respir J. 2024 Sep 5;64(3):2400197. doi: 10.1183/13993003.00197-2024. Print 2024 Sep. Eur Respir J. 2024. PMID: 38663975 Free PMC article.
852 results